WaveBreak Email Format

Biotechnology ResearchEngland, United Kingdom2-10 Employees

WaveBreak is a biotechnology research company based in Boston, Massachusetts, focused on advancing drug discovery for neurodegenerative diseases. Its work centers on identifying and targeting transient protein intermediates, or oligomers, that are linked to disease pathways and are not typically addressed by conventional approaches, with the aim of disrupting the molecular processes that generate these oligomers using small-molecule therapeutics. The company positions itself within the biopharmaceutical field by pursuing unmet medical needs in Parkinson’s disease, Lewy body dementia, Alzheimer’s disease, and ALS, directing its platform toward these conditions. WaveBreak operates with a small team and is rooted in the broader industry context of innovative strategies to access difficult targets in neurodegeneration. The organization is based in the Boston area, aligning with a regional ecosystem known for biotechnology research and development. A recent notable development includes continued progress in its platform as it targets the transient intermediates that drive disease pathways, reflecting its focus on translating fundamental insights into potential therapeutic approaches.

Get verified WaveBreak emails free

Company overview Employee directory